EUVIMEDEUVIMED entdecken
Crossref

Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan (lay summary)

ScienceLink

AfricArXiv · 03.07.2023

DOI: 10.21428/3b2160cd.432e820e ↗

Kurz gefasst

Fachartikel in der Zeitschrift AfricArXiv, online erschienen am 03.07.2023. Verfasst von ScienceLink.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

ScienceLink (2023). Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan (lay summary). AfricArXiv. https://doi.org/10.21428/3b2160cd.432e820e

Vancouver

ScienceLink. Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan (lay summary). AfricArXiv. 2023. doi:10.21428/3b2160cd.432e820e

BibTeX
@article{ScienceLink2023,
  author = {ScienceLink},
  title = {Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan (lay summary)},
  journal = {AfricArXiv},
  year = {2023},
  doi = {10.21428/3b2160cd.432e820e}
}
Kostenlos starten →